Exact Mass: 189.0920356
Exact Mass Matches: 189.0920356
Found 500 metabolites which its exact mass value is equals to given mass value 189.0920356,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Castanospermine
Castanospermine is a tetrahydroxyindolizidine alkaloid that consists of octahydroindolizine having four hydroxy substituents located at positions 1, 6, 7 and 8 (the 1S,6S,7R,8R,8aR-diastereomer). It has a role as a metabolite, an anti-HIV-1 agent, an anti-inflammatory agent and an EC 3.2.1.* (glycosidase) inhibitor. Castanospermine is a natural product found in Alexa grandiflora, Alexa wachenheimii, and other organisms with data available. A tetrahydroxyindolizidine alkaloid that consists of octahydroindolizine having four hydroxy substituents located at positions 1, 6, 7 and 8 (the 1S,6S,7R,8R,8aR-diastereomer). D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007004 - Hypoglycemic Agents > D065089 - Glycoside Hydrolase Inhibitors D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D004791 - Enzyme Inhibitors KEIO_ID C043 Castanospermine inhibits all forms of α- and β-glucosidases, especially glucosidase L.
Methyl indole-3-acetate
Indole-3-methyl acetate, also known as methyl indole-3-acetate (methyl-IAA), is a catabolite of tryptophan converted by the gut microbiota. After absorption through the intestinal epithelium, tryptophan catabolites enter the bloodstream and are later excreted in the urine (PMID: 30120222). Pediatric enthesitis-related arthritis (ERA) patients (i.e. spondyloarthropathy associated with inflammatory bowel disease) have intestinal inflammation and decreased gut microbial diversity. Such alterations in the gut microbiota resulted in the reduction of tryptophan metabolism and several tryptophan metabolites in pediatric ERA fecal samples, including indole-3-methyl acetate (PMID: 27786174). Indole-3-methyl acetate is found in apple, and has been isolated from immature seeds of beach pea (Lathyrus maritimus), Vicia amurensis, wild soybean (Glycine soja), lobiya (Vigna catiang var. sinensis) and hyacinth bean (Dolichos lablab). Isolated from immature seeds of beach pea (Lathyrus maritimus), Vicia amurensis, wild soybean (Glycine soja), lobiya (Vigna catiang variety sinensis) and hyacinth bean (Dolichos lablab). Indole-3-methyl acetate is found in many foods, some of which are gram bean, yellow wax bean, common bean, and sweet orange. Methyl 2-(1H-indol-3-yl)acetate is an endogenous metabolite.
Homocitrulline
Homocitrulline is a metabolite that can be detected in larger amounts in the urine of individuals with urea cycle disorders (OMIM 238970). The accumulation of carbamylphosphate due to depleted supply of ornithine for the urea cycle may be responsible for the enhanced synthesis of homocitrulline and homoarginine in some cases (PMID 2474087). Homocitrulline has been identified in the human placenta (PMID: 32033212). Homocitrulline is a metabolite that can be detected in larger amounts in the urine of individuals with urea cycle disorders (OMIM 238970). The accumulation of carbamylphosphate due to depleted supply of ornithine for the urea cycle may be responsible for the enhanced synthesis of homocitrulline and homoarginine in some cases (PMID 2474087). [HMDB] L-Homocitrulline is metabolized to homoarginine through homoargininosuccinate via the urea cycle pathway and its metabolic abnormality could lead to Lysinuric Protein Intolerance (LPI). L-Homocitrulline is metabolized to homoarginine through homoargininosuccinate via the urea cycle pathway and its metabolic abnormality could lead to Lysinuric Protein Intolerance (LPI).
Backebergine
A member of the class of isoquinolines carrying two methoxy substituents at positions 6 and 7.
Phensuximide
Phensuximide is an anticonvulsant in the succinimide class. It suppresses the paroxysmal three cycle per second spike and wave EEG pattern associated with lapses of consciousness in petit mal seizures. The frequency of attacks is reduced by depression of nerve transmission in the motor cortex. N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics > N03AD - Succinimide derivatives C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent
N-Nitrosoanatabine
C10H11N3O (189.09020759999999)
3-Indolepropionic acid
3-Indolepropionic acid is shown to be a powerful antioxidant and has potential in the treatment for Alzheimer’s disease.
Indole-3-propionic acid
Indole-3-propionic acid (IPA, indole-3-propionate, or indole propionic acid), is a reductive product of tryptophan formed by bacteria in the gastrointestinal tract of mammals and birds (PMID:29168502). It is endogenously produced by human microbiota and has only been detected in vivo (PMID:19234110). While many microbial metabolites produced in the gut are toxic or act as uremic toxins (when they are reabsorbed through the gut epithelia), indole-3-propionic acid is a very beneficial microbial metabolite (PMID:30914514, 30862081, 29238104). In limited studies, urinary IPA correlates positively with disease and it remains unclear if this represents host bacteria responding to pathology via the production of IPA, or intestinal permeability changes leading to higher absorption and excretion of IPA, or inflammatory changes within kidneys leading to high excretion of IPA (PMID:32132996). Indole-3-propionic acid is a remarkably strong antioxidant (PMID:10721080). It is an even more potent scavenger of hydroxyl radicals than melatonin, the most potent scavenger of hydroxyl radicals synthesized by the human body. Similar to melatonin but unlike other antioxidants, indole-3-propionic acid scavenges radicals without subsequently generating reactive and pro-oxidant intermediate compounds (PMID:9928448, 10419516). Indole-3-propionic acid has been shown to prevent oxidative stress and the death of primary neurons and neuroblastoma cells exposed to the amyloid beta-protein in the form of amyloid fibrils, one of the most prominent neuropathologic features of Alzheimers disease. 3-Indolepropionic acid also shows a strong level of neuroprotection in two other paradigms of oxidative stress. (PMID 10419516) More recently it has been found that higher indole-3-propionic acid levels in serum/plasma are associated with a reduced likelihood of type 2 diabetes and with higher levels of consumption of fibre-rich foods (PMID:28397877). Studies have shown that serum levels of indole-3-propionic acid are positively correlated with dietary fibre intake and negatively correlated with C-reactive protein levels (PMID:29795366). Indole-3-propionic acid is a marker for the presence of Clostridium sporogenes in the gut. Higher levels are associated with higher levels of Clostridium sporogenes (PMID:7378938). In addition to its useful physiological role in mammals, indole-3-propionic acid is a plant hormone with functions similar to indole-3-acetic acid (or IAA), the major plant auxin. Recent studies have shed some light on additional mechanisms of action of IPA. In the intestine, IPA could serve as a ligand to an adopted orphan nuclear receptor, Pregnane X receptor (PXR) and act as an anti-inflammatory agent (PMID:25065623). This property has allowed investigators to develop more potent analogs targeting PXR (PMID:32153125). Other tissues may also be targeted by IPA in a similar manner (PMID:31211619). Indole-3-propionate (IPA), a deamination product of tryptophan formed by symbiotic bacteria in the gastrointestinal tract of mammals and birds. 3-Indolepropionic acid has been shown to prevent oxidative stress and death of primary neurons and neuroblastoma cells exposed to the amyloid beta-protein in the form of amyloid fibrils, one of the most prominent neuropathologic features of Alzheimers disease. 3-Indolepropionic acid also shows a strong level of neuroprotection in two other paradigms of oxidative stress. (PMID: 10419516) [HMDB]. 1H-Indole-3-propanoic acid is found in common pea. 3-Indolepropionic acid is shown to be a powerful antioxidant and has potential in the treatment for Alzheimer’s disease.
Glycylglycylglycine
Glycylglycylglycine, also known as GGG or triglycine, belongs to the class of organic compounds known as oligopeptides. These are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. A tripeptide in which three glycine units are linked via peptide bonds in a linear sequence. Glycylglycylglycine has been detected, but not quantified, in fruits. This could make glycylglycylglycine a potential biomarker for the consumption of these foods. Glycylglycylglycine is a potentially toxic compound.
N-Lactoylvaline
N-Lactoylvaline is a lactoyl derivative of phenylalanine. N-Lactoyl-amino acids are ubiquitous pseudodipeptides of lactic acid and amino acids that are rapidly formed by reverse proteolysis. A protease, cytosolic nonspecific dipeptidase 2 (CNDP2), catalyzes their formation. The plasma levels of these metabolites strongly correlate with plasma levels of lactate and amino acid (PMID: 25964343).
N-Methylcalystegine B2
N-Methylcalystegine B2 is an alkaloid from the roots of Lycium chinense (Chinese boxthorn). Alkaloid from the roots of Lycium chinense (Chinese boxthorn)
S-Prenyl-L-cysteine
S-Prenyl-L-cysteine is catalysed by prenylcysteine oxidase to form L-cysteine.A flavoprotein (FAD). Cleaves the thioether bond of S-prenyl-L-cysteines, such as S-farnesylcysteine and S-geranylgeranylcysteine. N-Acetyl-prenylcysteine and. prenylcysteinyl peptides are not substrates. This reaction may represent the final. step in the degradation of prenylated proteins in mammalian tissues. The enzyme is originally thought to be a simple lyase so it had been classified as. EC 4.4.1.18. S-Prenyl-L-cysteine is catalysed by prenylcysteine oxidase to form L-cysteine.A flavoprotein (FAD). Cleaves the thioether bond of S-prenyl-L-cysteines, such as S-farnesylcysteine and S-geranylgeranylcysteine. N-Acetyl-prenylcysteine and
Asparaginylglycine
Asparaginylglycine is a dipeptide composed of asparagine and glycine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Glycyl-Asparagine
Glycyl-Asparagine is a dipeptide composed of glycine and asparagine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
1-hydroxyhexanoylglycine
1-Hydroxyhexanoylglycine is classified as a member of the Alpha amino acids. Alpha amino acids are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). 1-Hydroxyhexanoylglycine is considered to be soluble (in water) and acidic.ÂÂ
2-hydroxyhexanoylglycine
2-Hydroxyhexanoylglycine is classified as a member of the N-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. 2-Hydroxyhexanoylglycine is considered to be slightly soluble (in water) and acidic.
3-hydroxyhexanoylglycine
3-Hydroxyhexanoylglycine is classified as a member of the N-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. 3-Hydroxyhexanoylglycine is considered to be slightly soluble (in water) and acidic.
4-hydroxyhexanoylglycine
4-Hydroxyhexanoylglycine is classified as a member of the N-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. 4-Hydroxyhexanoylglycine is considered to be slightly soluble (in water) and acidic.
5-hydroxyhexanoylglycine
5-Hydroxyhexanoylglycine is classified as a member of the N-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. 5-Hydroxyhexanoylglycine is considered to be slightly soluble (in water) and acidic.
1-Carboxyethylvaline
1-Carboxyethylvaline belongs to the class of organic compounds known as valine and derivatives. These are compounds containing valine or a derivative thereof resulting from reaction of valine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. 1-Carboxyethylvaline was identified as one of forty plasma metabolites that could be used to predict gut microbiome Shannon diversity (PMID: 31477923). Shannon diversity is a metric that summarizes both species abundance and evenness, and it has been suggested as a marker for microbiome health.
Caracemide
C471 - Enzyme Inhibitor > C2150 - Ribonucleotide Reductase Inhibitor
3-Indolepropionic acid
3-Indolepropionic acid is shown to be a powerful antioxidant and has potential in the treatment for Alzheimer’s disease.
1-(2,7-dimethylpyrazolo[1,5-a]pyrimidin-6-yl)ethanone
C10H11N3O (189.09020759999999)
5-methyl-N-(pyridin-3-ylmethyl)isoxazol-3-amine
C10H11N3O (189.09020759999999)
(R)-2-cyano-1-phenylethyl acetate|(S)-2-cyano-1-phenylethyl acetate|(S)-3-acetoxy-3-phenylpropanenitrile
1,2,3,4,7-Pentahydroxy-6-nitrobicyclo[3.3.0]octane
3-Methyl-5-(2-hydroxy-5-methylphenyl)-isoxazol|3-Methyl-5-(2-hydroxy-5-methylphenyl)isoxazol|3-Methyl-5-(2hydroxy-5-methylphenyl)isoxazol|3-Methyl-5-<2-hydroxy-5-methyl-phenyl>-isoxazol|4-methyl-2-(3-methyl-isoxazol-5-yl)-phenol
1,2-O-Isopropylidene-alpha-D-Furanose-3-Amino-3-deoxyribose
L-Homocitrulline
A L-lysine derivative that is L-lysine having a carbamoyl group at the N(6)-position. It is found in individuals with urea cycle disorders. L-Homocitrulline is metabolized to homoarginine through homoargininosuccinate via the urea cycle pathway and its metabolic abnormality could lead to Lysinuric Protein Intolerance (LPI). L-Homocitrulline is metabolized to homoarginine through homoargininosuccinate via the urea cycle pathway and its metabolic abnormality could lead to Lysinuric Protein Intolerance (LPI).
Homocitrulline
L-Homocitrulline is metabolized to homoarginine through homoargininosuccinate via the urea cycle pathway and its metabolic abnormality could lead to Lysinuric Protein Intolerance (LPI). L-Homocitrulline is metabolized to homoarginine through homoargininosuccinate via the urea cycle pathway and its metabolic abnormality could lead to Lysinuric Protein Intolerance (LPI).
Indole-3-methyl acetate
Methyl 2-(1H-indol-3-yl)acetate is an endogenous metabolite.
Methyl indole-3-acetate
Methyl 2-(1H-indol-3-yl)acetate is an endogenous metabolite.
Asn-gly
A dipeptide composed of L-asparagine and glycine joined by a peptide linkage.
gly-asn
A dipeptide formed from glycine and L-asparagine residues.
Meiaa
Methyl 2-(1H-indol-3-yl)acetate is an endogenous metabolite.
1H-Benzimidazole-2-propanamide(9CI)
C10H11N3O (189.09020759999999)
Cyclopentanecarboxylic acid, 4-amino-2,3-dihydroxy-, ethyl ester,
2-(3-(PYRIDIN-4-YL)-1H-PYRAZOL-1-YL)ETHANOL
C10H11N3O (189.09020759999999)
2-(4-aminophenyl)-3-methyl-1H-pyrazol-5-one
C10H11N3O (189.09020759999999)
(1S)-1-(3-fluoro-2-methylphenyl)ethanamine,hydrochloride
C9H13ClFN (189.07205000000002)
(S)-1-(4-Fluoro-3-methylphenyl)ethanamine hydrochloride
C9H13ClFN (189.07205000000002)
3-AMINO-2-ETHYL-4(3H)-QUINAZOLINONE
C10H11N3O (189.09020759999999)
ETHYL PHENYLCYANOACETATE
An alpha-substituted cyanoacetate ester that consists of ethyl cyanoacetate bearing an alpha-phenyl substituent.
1-(4-METHOXY-PHENYL)-1H-PYRAZOL-3-YLAMINE
C10H11N3O (189.09020759999999)
2-(3-aminophenyl)-2,4-dihydro-5-methyl-3H-pyrazol-3-one
C10H11N3O (189.09020759999999)
(R)-1-(2-Fluorophenyl)propan-1-amine hydrochloride
C9H13ClFN (189.07205000000002)
(1S)-1-(5-fluoro-2-methylphenyl)ethanamine,hydrochloride
C9H13ClFN (189.07205000000002)
(S)-1-(2-Fluoro-5-Methylphenyl)ethanamine hydrochloride
C9H13ClFN (189.07205000000002)
2-(methylaminomethyl)-1H-quinazolin-4-one
C10H11N3O (189.09020759999999)
(5-Methyl-2-phenyl-2H-1,2,3-triazol-4-yl)methanol
C10H11N3O (189.09020759999999)
2-(4-Morpholinyl)Isonicotinonitrile
C10H11N3O (189.09020759999999)
4-(4-METHOXYPHENYL)-1H-PYRAZOL-3-AMINE
C10H11N3O (189.09020759999999)
1-(METHOXYIMINO)-2,3-DIHYDRO-1H-INDENE-5-CARBALDEHYDE
(1R)-1-(5-fluoro-2-methylphenyl)ethanamine,hydrochloride
C9H13ClFN (189.07205000000002)
(R)-1-(2-Fluoro-5-Methylphenyl)ethanamine hydrochloride
C9H13ClFN (189.07205000000002)
N-{[(2-Methyl-2-Propanyl)Oxy]Carbonyl}-L-(1-13C)Alanine
(S)-1-(2-Fluorophenyl)propan-1-amine hydrochloride
C9H13ClFN (189.07205000000002)
(2-BENZHYDRYLOXYCARBONYLAMINO-6-OXO-1,6-DIHYDRO-PURIN-9-YL)-ACETICACID
C10H11N3O (189.09020759999999)
(1-BENZYL-1H-1,2,3-TRIAZOL-4-YL)METHANOL
C10H11N3O (189.09020759999999)
[2-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]METHANOL
C10H11N3O (189.09020759999999)
Pyrido[2,3-b]pyrazine-2,3-diamine, N,N-dimethyl- (9CI)
[4-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]METHANOL
C10H11N3O (189.09020759999999)
9-Azabicyclo[3.3.1]nonan-3-one,9-methyl-, hydrochloride (1:1)
5-(3-Methoxyphenyl)-1H-iMidazol-2-aMine
C10H11N3O (189.09020759999999)
5-(4-Methoxyphenyl)-1H-imidazol-2-amine
C10H11N3O (189.09020759999999)
Pyrido[3,2-e]pyrrolo[1,2-a]pyrazin-6(5H)-one, 6a,7,8,9-tetrahydro- (9CI)
C10H11N3O (189.09020759999999)
1-(4-fluorophenyl)propan-2-amine hydrochloride
C9H13ClFN (189.07205000000002)
4-(5-ethyl-1,2,4-oxadiazol-3-yl)aniline
C10H11N3O (189.09020759999999)
5-(3-Methoxyphenyl)-2H-pyrazol-3-ylamine
C10H11N3O (189.09020759999999)
METHYL-(3-PHENYL-[1,2,4]OXADIAZOL-5-YLMETHYL)-AMINE
C10H11N3O (189.09020759999999)
C-(3-Benzyl-[1,2,4]oxadiazol-5-yl)-methylaminehydrochloride
C10H11N3O (189.09020759999999)
5-(2-Methoxy-phenyl)-1H-pyrazol-3-ylamine
C10H11N3O (189.09020759999999)
5-(2-Methoxyphenyl)-1H-pyrazol-3-amine
C10H11N3O (189.09020759999999)
1H-Indole-3-carboxylic acid, 6-Methyl-, Methyl ester
(1R)-1-(3-fluoro-2-methylphenyl)ethanamine,hydrochloride
C9H13ClFN (189.07205000000002)
4-amino-2-pyrrolidin-1-ylpyrimidine-5-carbonitrile
2-(4-AMINOMETHYL-OXAZOL-2-YL)-PHENYLAMINE
C10H11N3O (189.09020759999999)
ALLYL-(3-METHYL-1,1-DIOXO-TETRAHYDRO-1LAMBDA6-THIOPHEN-3-YL)-AMINE
1-ethyl-3-hydrazono-1,3-dihydro-indol-2-one
C10H11N3O (189.09020759999999)
1H-Imidazo[1,2-a]benzimidazole,2,3-dihydro-6-methoxy-(9CI)
C10H11N3O (189.09020759999999)
3H-Pyrazol-3-one,2-(4-aminophenyl)-2,4-dihydro-5-methyl-
C10H11N3O (189.09020759999999)
1,5-dimethyl-1H-indole-2-carboxylic acid(SALTDATA: FREE)
tert-Butyl (N-hydroxycarbamimidoylmethyl)carbamate
2-amino-2-cyano-n-p-toylyl-acetamide
C10H11N3O (189.09020759999999)
5-methoxy-1h-indole-3-carboxamidine
C10H11N3O (189.09020759999999)
1-METHYL-1H-INDOLE-3-CARBOHYDRAZIDE
C10H11N3O (189.09020759999999)
(5-benzyl-1,2,4-oxadiazol-3-yl)methanamine
C10H11N3O (189.09020759999999)
1-(4-METHOXYBENZYL)-1,2,4-TRIAZOLE
C10H11N3O (189.09020759999999)
Carbamic acid,N-(4-methylphenyl)-, 2-propyn-1-yl ester
3-Fluoroamphetamine (hydrochloride)
C9H13ClFN (189.07205000000002)
3-(4-Methoxyphenyl)-1H-pyrazol-5-amine
C10H11N3O (189.09020759999999)
Pyrido[2,3-b]pyrazin-2(1H)-one, 3-(1-methylethyl)- (9CI)
C10H11N3O (189.09020759999999)
Pyrido[2,3-b]pyrazin-3(4H)-one, 2-(1-methylethyl)- (9CI)
C10H11N3O (189.09020759999999)
Pyrido[2,3-b]pyrazin-6(4H)-one, 3-amino-8-methyl- (9CI)
C10H11N3O (189.09020759999999)
(2-imidazol-1-yl-6-methylpyrimidin-4-yl)methanamine
1H-Benzimidazole-2-acetamide,N-methyl-(9CI)
C10H11N3O (189.09020759999999)
2-(2-AMINOETHYL)QUINAZOLIN-4(3H)-ONE
C10H11N3O (189.09020759999999)
[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanamine
C10H11N3O (189.09020759999999)
[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]methanamine
C10H11N3O (189.09020759999999)
1-(4-Methoxybenzyl)-1H-1,2,4-triazole
C10H11N3O (189.09020759999999)
Azolimine
C10H11N3O (189.09020759999999)
C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49186 - Potassium-Sparing Diuretic
3-Isocyanatopropyltrimethoxysilane
C7H15NO3Si (189.08211599999998)
Pyrimido[1,2-a]benzimidazol-8-ol, 1,2,3,4-tetrahydro- (9CI)
C10H11N3O (189.09020759999999)
2-ISOPROPYL-[1,2,4]TRIAZOLO[1,5-A]PYRIDINE-6-CARBALDEHYDE
C10H11N3O (189.09020759999999)
Benzenemethanamine, 4-fluoro-N,alpha-dimethyl- (9CI)
C9H13ClFN (189.07205000000002)
Pyrido[2,3-b]pyrazin-3(4H)-one, 2,6,8-trimethyl- (9CI)
C10H11N3O (189.09020759999999)
1H-Benzimidazole-1-carboxamide,N,N-dimethyl-(9CI)
C10H11N3O (189.09020759999999)
1H-Benzimidazole-1-acetamide,2-methyl-(9CI)
C10H11N3O (189.09020759999999)
Pyrrolidine, 1-(2-chloro-1-oxopropyl)-2,2-dimethyl- (9CI)
methyl-(5-phenyl-[1,3,4]oxadiazol-2-ylmethyl)-amine
C10H11N3O (189.09020759999999)
1-isopropyl-1h-benzo[d][1,2,3]triazole-5-carbaldehyde
C10H11N3O (189.09020759999999)
4-(4-hydroxyphenyl)-5-methyl-1,3-hiazol-2-amine
C10H11N3O (189.09020759999999)
(5-METHYL-4,5-DIHYDRO-1H-PYRAZOL-1-YL)(PYRIDIN-3-YL)METHANONE
C10H11N3O (189.09020759999999)
(R)-1-(4-Fluoro-3-methylphenyl)ethanamine hydrochloride
C9H13ClFN (189.07205000000002)
2-(3-(pyridin-2-yl)-1H-pyrazol-1-yl)ethanol
C10H11N3O (189.09020759999999)
[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]METHANOL
C10H11N3O (189.09020759999999)
4-(4-AMINOMETHYL-OXAZOL-2-YL)-PHENYLAMINE
C10H11N3O (189.09020759999999)
4-methoxy-1h-indole-3-carboxamidine
C10H11N3O (189.09020759999999)
2-(3-PHENYL-[1,2,4]OXADIAZOL-5-YL)-ETHYLAMINE
C10H11N3O (189.09020759999999)
2,2-DIMETHYL-2,3-DIHYDRO-1-BENZOFURAN-7-YL ISOCYANATE
N,N-dimethyl-1H-indazole-3-carboxamide
C10H11N3O (189.09020759999999)
6-morpholin-4-ylpyridine-2-carbonitrile
C10H11N3O (189.09020759999999)
2-methyl-5-(1-methylpyrazol-4-yl)pyridin-3-ol
C10H11N3O (189.09020759999999)
9-Methyl-5,6,7,8-tetrahydrotetrazolo[5,1-b]quinazoline
Trimethylsilyl (acetylamino)acetate
C7H15NO3Si (189.08211599999998)
(3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one
3-Formyl-2-hydroxy-5-methyl-hexanoic acid hydroxyamide
2-{[Formyl(hydroxy)amino]methyl}-4-methylpentanoic acid
(2R)-2-{[Formyl(hydroxy)amino]methyl}hexanoic acid
(2S)-4-amino-2-[(azaniumylacetyl)amino]-4-oxobutanoate
(R)-3-[(R)-3-hydroxybutanoyloxy]butanoate
A hydroxy monocarboxylic acid anion that is the conjugate base of (R)-3-[(R)-3-hydroxybutanoyloxy]butanoic acid
S-Prenyl-L-cysteine
A prenylcysteine where the prenyl moiety is attached to the side-chain sulfur atom of L-cysteine.
(2S)-2-[[(1R)-1-carboxyethyl]amino]-3-methylbutanoic acid
3-Hydroxy-2-isopropyl-4-methoxy-4-oxobutanoate
The conjugate base of a succinic acid monoester having an isopropyl substituent at the 2-position and a hydroxy substituent at the 3-position.
3-Methyl-4-oxo-1,2,3,4-tetrahydroquinoline-2-carbaldehyde
(3R)-4-[dimethyl(trideuteriomethyl)azaniumyl]-3-formyloxybutanoate
N-[(3S,4R,5S)-4,5-dihydroxy-1-oxohexan-3-yl]acetamide
Phensuximide
N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics > N03AD - Succinimide derivatives C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent
methyl 2-(1H-indol-3-yl)acetate
Methyl 2-(1H-indol-3-yl)acetate is an endogenous metabolite.
3-[(2R)-1-nitroso-3,4-dihydro-2H-pyridin-2-yl]pyridine
C10H11N3O (189.09020759999999)
L-homocitrulline zwitterion
An amino acid zwitterion of L-homocitrulline arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.
Gly-Asn zwitterion
A peptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Gly-Asn.
3-(1H-Indol-3-yl)propanoic acid
An indol-3-yl carboxylic acid that is propionic acid substituted by a 1H-indol-3-yl group at position 3.
(3S)-3-hydroxy-L-enduracididine(1+)
An alpha-amino-acid cation obtained by deprotonation of the carboxy group and protonation of the amino and guanidino groups of (3S)-3-hydroxy-L-enduracididine.
S-prenyl-L-cysteine zwitterion
An L-alpha-amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of S-prenyl-L-cysteine; major species at pH 7.3.